FDA Panel Backs Eased HIV Test Regs
Executive Summary
A US FDA advisory committee said the agency should move forward with a proposal to down-classify some types of HIV tests, but panelists said the agency’s planned special controls might be too stringent to encourage innovation in the space.
You may also be interested in...
Special Controls For HIV Tests Under FDA Review
The US FDA is considering reclassifying certain HIV tests, a proposal that has been on the agency’s radar for a few years.
FDA Panel To Ponder Down-Classifying HIV Tests
US FDA's Blood Products Advisory Committee will consider the agency's proposal to ease regulations on some HIV tests. The agency hopes a streamlined approval process would encourage HIV test development, and ultimately make routine testing for the virus more accessible.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.